DBV Technologies (DBVT) Capital Expenditures (2020 - 2026)

DBV Technologies (DBVT) posted Capital Expenditures of $400000.0 for Q2 2026, little changed sequentially from $400000.0 in Q1 2026.

DBV Technologies (DBVT) Capital Expenditures (2020 - 2026) Analysis & Trends

DBV Technologies has reported Capital Expenditures for 7 years, with the latest figure at $400000.0 in Q2 2026.

Quarterly Capital Expenditures changed N/A year-over-year to $400000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.3 million (up 391.51% YoY) and the FY2025 annual result came in at $532000.0, down 77.25% from the prior year.
Capital Expenditures held at $400000.0 in Q2 2026 per DBVT's latest filing, from $400000.0 in the prior quarter.
Over five years, Capital Expenditures peaked at $1.3 million in Q1 2024 and troughed at -$125000.0 in Q4 2024.
A 5-year average of $318812.5 and a median of $295000.0 in 2022 frame the typical range for Capital Expenditures.
The sharpest annual moves came in 2022 and 2024: Capital Expenditures surged 2969.23% in 2022, then sank 135.51% in 2024.
Over 5 years, Capital Expenditures stood at $12000.0 in 2022, then soared by 2833.33% to $352000.0 in 2023, then tumbled by 135.51% to -$125000.0 in 2024, then jumped by 398.4% to $373000.0 in 2025, then climbed by 7.24% to $400000.0 in 2026.
According to Business Quant data, Capital Expenditures over the past three periods registered $400000.0, $400000.0, and $373000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Capital Expenditures (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	112.20 Mn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	240.20 Mn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	2.29 Mn
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	25.02 Mn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	572,662.23
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	251.02 Mn
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	34.68 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	6.26 Mn
10	DBV Technologies	6.08 Bn	5.90 Bn	-	400,000.00

Download Data